SCHEMBL6804501

SCHEMBL6804501

Cc1[nH]c2c(C(=O)Nc3cccc(-c4cncnc4)c3)cccc2c1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.46
CNR2 P34972 1/20 0.46
BRD4 O60885 2/20 0.43
KMT2A Q03164 2/20 0.41
GRM5 P41594 1/20 0.41
CREBBP Q92793 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
MAPT P10636 2/20 0.40
KDM4E B2RXH2 1/20 0.40
LMNA P02545 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
HDAC3 O15379 1/20 0.40
HDAC1 Q13547 1/20 0.40
FGFR1 P11362 2/20 0.40
TP53 P04637 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6804288 0.87 LCK (0.45) CNR1CNR2KMT2AGRM5MAPT
SCHEMBL6833155 0.83 CNR1 (0.47) CNR1CNR2KMT2AGRM5MAPT
SCHEMBL6833169 0.81 DYRK1A (0.44) BRD4KMT2AGRM5SCN4ASCN9A
SCHEMBL6804275 0.75 MAPK14 (0.48) BTKABL1KITKDRCSF1R
SCHEMBL6800445 0.74 KMT2A (0.49) KMT2AMAPTKDM4ECYP1A2BTK
SCHEMBL6803412 0.73 KMT2A (0.39) KMT2AGRM5L3MBTL1HDAC3HDAC1
SCHEMBL25037735 0.72 SETD2 (0.58) CNR1CNR2MAPTABL1KIT
SCHEMBL6803749 0.72 KMT2A (0.49) KMT2AMAPTKDM4ELMNACYP1A2
SCHEMBL6756890 0.72 DYRK1A (0.44) KMT2AGRM5CREBBPKDM4EHDAC3
SCHEMBL2646435 0.71 CNR1 (0.63) CNR1CNR2MAPTCYP1A2FGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040266774-A1 Amide compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-12-30 US disclosed
US-6770667-B1 N-((IMIDAZOLYL)-PHENYL)-FLUORENE-1-CARBOXAMIDE DERIVATIVES; 5-HYDROXYTRYPTAMINE (5-HT) ANTAGONISTS; PSYCHOLOGICAL, NERVOUS SYSTEM, EATING, BRAIN AND SLEEP DISORDERS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040266774-A1 Amide compounds TPH1, HTR1A, HTR5A CNR1 51/4885CNR2 61/4885BRD4 601/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.